The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Dendreon
Research Funding - Dendreon
Relationship between smoking, prognostic factors, and outcomes in patient (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving sipuleucel-T (sip-T): Preliminary analysis of the PROCEED registry.
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Eisai; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation; Sanofi
 
Celestia S. Higano
Employment - Cell Therapeutics (I)
Leadership - Cell Therapeutics (I)
Stock and Other Ownership Interests - Cell Therapeutics (I)
Consulting or Advisory Role - AbbVie; Bayer; BHR Pharma; Dendreon; Ferring; Genentech; Johnson & Johnson; Medivation; Orion; Pfizer; Sanofi
Research Funding - Algeta/Bayer (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Exelixis (Inst); Genentech (Inst); Medivation (Inst); Millennium (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst)
Travel, Accommodations, Expenses - AbbVie; Amgen; Astellas Pharma; Bayer; Dendreon; Ferring; Genentech; Johnson & Johnson; Medivation; Ockham; Orion; Pfizer; Sanofi; Teva
 
Oliver Sartor
No Relationships to Disclose
 
David F. Penson
Consulting or Advisory Role - Astellas Pharma; Dendreon; Medivation
Research Funding - Astellas Pharma (Inst); Medivation (Inst)
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Abbvie; Bavarian Nordic; Dava Oncology; Dendreon; Endocyte; Janssen Oncology; Mannkind; Pfizer; UpToDate
Consulting or Advisory Role - Amgen; AVEO; Bayer; BIND Biosciences; Cerulean Pharma; Churchill Pharmaceuticals; Genentech/Roche; HERON; Janssen Biotech; Labceutics; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Caris MPI; Dendreon; Genentech/Roche; GlaxoSmithKline; Medivation; Millennium; Pfizer; Sanofi
Research Funding - Endocyte (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Parexel (Inst); Progenics (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Celgene; Dendreon; Exelixis; Genentech/Roche; Novartis; Pfizer; US Oncology
 
Shaker R. Dakhil
No Relationships to Disclose
 
Christopher Michael Pieczonka
Stock and Other Ownership Interests - Augmenix
Honoraria - Astellas Oncology; Bayer
Consulting or Advisory Role - Bayer; Dendreon; Janssen
Speakers' Bureau - Astellas Oncology; Bayer; Dendreon; Janssen
Research Funding - Astellas Oncology (Inst); Bayer (Inst); Dendreon (Inst); Janssen (Inst)
 
Jeffrey L. Vacirca
Employment - Caris Life Sciences; Flatiron Health; HERON; Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Caris Life Sciences; Flatiron Health
Honoraria - Caris Life Sciences; HERON; Spectrum Pharmaceuticals
Consulting or Advisory Role - HERON; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Caris Life Sciences; Flatiron Health; HERON; Spectrum Pharmaceuticals
 
Ronald F. Tutrone
Stock and Other Ownership Interests - Nymox; Sophiris Bio
Consulting or Advisory Role - Medivation/Astellas; Pfizer
Speakers' Bureau - Dendreon; Medivation/Astellas
Research Funding - Advaxis (Inst); Allena Pharmaceuticals (Inst); Allergan (Inst); American Medical Systems (Inst); Bayer (Inst); Boston Scientific (Inst); Genentech/Roche (Inst); Genomic Health (Inst); Janssen Oncology (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Mundipharma (Inst); Neotract (Inst); Nymox (Inst); Sophiris Bio (Inst)
 
Luke T. Nordquist
No Relationships to Disclose
 
Nancy N. Chang
Employment - Dendreon
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
 
Matthew R. Cooperberg
Honoraria - Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Myriad Pharmaceuticals
Research Funding - GenomeDx (Inst); Genomic Health (Inst); Myriad Pharmaceuticals (Inst)